Product Information

LISDEXAMFETAMINE 40 MG TB CHEW is a generic product labeled by SpecGx LLC, priced at $3.7243 per EA under NDC 00406512701. Its NADAC has been published 42 times since Nov 5, 2025.

FDA first approved this application on Dec 17, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 40 MG TB CHEW

Lisdexamfetamine Dimesylate
$3.7243per EA
DEA Schedule CII

Strength

40 mg/1

Manufacturer

SpecGx LLC

NDC

00406512701

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218850

FDA Approved

12/17/2024

TE Code

AB

On Market Since

12/17/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 40 MG TB CHEW has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 40.7%. The table below summarizes its recorded NADAC range and movement.

Current price$3.7243 per EA
All-time high$6.3117 (Jan 14, 2026)
All-time low$3.7243 (Aug 19, 2026)
52-week high$6.3117
52-week low$3.7243
Median price$5.0157
Average price$5.1427
Largest weekly change-10.8% (Mar 18, 2026)
Weeks tracked42
Tracking sinceNov 5, 2025

Price History

1W

-2.3%

1M

-2.3%

3M

-14.0%

6M

-33.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-40.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lisdexamfetamine Dimesylate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 40 MG TB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 40 MG TB CHEW, manufactured by SpecGx LLC, is $3.7243 per EA (NDC 00406512701), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 40 MG TB CHEW changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 40 MG TB CHEW has declined 40.7%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 40 MG TB CHEW?

Since Nov 5, 2025, the NADAC for LISDEXAMFETAMINE 40 MG TB CHEW has ranged from a low of $3.7243 (Aug 19, 2026) to a high of $6.3117 (Jan 14, 2026), with a median of $5.0157 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 40 MG TB CHEW?

No other NADAC-published product currently shares the active ingredient and strength of LISDEXAMFETAMINE 40 MG TB CHEW in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LISDEXAMFETAMINE 40 MG TB CHEW?

LISDEXAMFETAMINE 40 MG TB CHEW (NDC 00406512701) is labeled by SpecGx LLC, and CMS classifies it as a generic product.